Isoxazoline and isoxazole fibrogen receptor antagonists
US6114328A · kind A · utility
16Cited by
4References
49Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 1997 |
| Grant date | Sep 5, 2000 |
| Priority date | — |
| Expiry date | Nov 25, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel isoxazolines and isoxazoles which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex or the vitronectin receptor, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.